Home › Follicular Lymphoma › Texas › Houston

Pag-aaral pangklinika para sa Follicular Lymphoma sa Houston, TX

Isang pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Texas Children's Hospital, Houston

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Nagre-recruitPhase 1/2

Research Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Md Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Baylor College of Medicine, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Nagre-recruitPhase 1/2

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Nagre-recruitPhase 3

Center for Oncology and Blood Disorders, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06091254

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Nagre-recruitPhase 2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06043323

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06108232

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

University of Texas MD Anderson Cancer Center, Houston

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Nagre-recruitPhase 1

The University of TX MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07424833

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Nagre-recruitPhase 2

Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston

Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT05951777

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Oncology Consultants, Houston
University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Follicular Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.